[{"address1": "2500 Westchester Ave.", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 951736, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 619940, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 676372, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven A. Weissman Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anita  Cornet", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bobby  Horn", "title": "Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3547, "open": 0.35, "dayLow": 0.33, "dayHigh": 0.3549, "regularMarketPreviousClose": 0.3547, "regularMarketOpen": 0.35, "regularMarketDayLow": 0.33, "regularMarketDayHigh": 0.3549, "payoutRatio": 0.0, "beta": 0.991, "forwardPE": -0.43987015, "volume": 5410051, "regularMarketVolume": 5410051, "averageVolume": 1292709, "averageVolume10days": 491190, "averageDailyVolume10Day": 491190, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 20990864, "fiftyTwoWeekLow": 0.305, "fiftyTwoWeekHigh": 2.95, "fiftyDayAverage": 0.41306, "twoHundredDayAverage": 0.58309, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2213196, "profitMargins": 0.0, "floatShares": 55631254, "sharesOutstanding": 61974800, "sharesShort": 911872, "sharesShortPriorMonth": 1416555, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0147, "heldPercentInsiders": 0.02226, "heldPercentInstitutions": 0.17958, "shortRatio": 1.49, "shortPercentOfFloat": 0.0184, "impliedSharesOutstanding": 61974800, "bookValue": 0.313, "priceToBook": 1.0821086, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -33971000, "trailingEps": -0.86, "forwardEps": -0.77, "enterpriseToEbitda": 0.041, "52WeekChange": -0.81413615, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 0.3387, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.4, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 25009000, "totalCashPerShare": 0.404, "ebitda": -53859000, "totalDebt": 814000, "quickRatio": 2.486, "currentRatio": 2.653, "debtToEquity": 4.341, "returnOnAssets": -1.03151, "returnOnEquity": -1.5718601, "freeCashflow": -28761376, "operatingCashflow": -28474000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CGTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-08", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1633699800000, "regularMarketChange": -0.016000003, "regularMarketDayRange": "0.33 - 0.3549", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1292709, "fiftyTwoWeekLowChange": 0.03369999, "fiftyTwoWeekLowChangePercent": 0.11049177, "fiftyTwoWeekRange": "0.305 - 2.95", "fiftyTwoWeekHighChange": -2.6113, "fiftyTwoWeekHighChangePercent": -0.88518643, "fiftyTwoWeekChangePercent": -81.41361, "earningsTimestamp": 1746617400, "earningsTimestampStart": 1746617400, "earningsTimestampEnd": 1746617400, "earningsCallTimestampStart": 1742472000, "earningsCallTimestampEnd": 1742472000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.86, "epsForward": -0.77, "epsCurrentYear": -0.4, "priceEpsCurrentYear": -0.84674996, "fiftyDayAverageChange": -0.07436001, "fiftyDayAverageChangePercent": -0.1800223, "twoHundredDayAverageChange": -0.24439001, "twoHundredDayAverageChangePercent": -0.41912913, "regularMarketChangePercent": -4.510855, "regularMarketPrice": 0.3387, "marketState": "REGULAR", "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "corporateActions": [], "regularMarketTime": 1746725137, "exchange": "NCM", "messageBoardId": "finmb_39366358", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cognition Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]